JUAN CARLOS
ASTORGA BURGO
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaCentro Nacional de Investigaciones Cardiovasculares Carlos III-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588